Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases
D Zorzi YS Chun DC Madoff EK Abdalla JN Vauthey 2008 Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases Ann Surg Oncol 1510 2765 2772
Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab
DOI:10.1245/s10434-009-0447-z
Aussilhou B, Dokmak S, Faivre S, et al. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. DOI:10.1245/s10434- 009-0447-z.
Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases (abstract 295)
January 15-17, San Francisco, CA
Zorzi D, Kishi Y, Maru DM, et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases (abstract 295). American society of clinical oncology 2009 gastrointestinal cancers symposium, January 15-17, 2009, San Francisco, CA.
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
DOI 10.1097/01.sla.0000193603.26265.c3
M Karoui C Penna M Amin-Hashem 2006 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 2431 1 7 (Pubitemid 43054046)
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: Myth or reality?
R Adam DA Wicherts RJ de Haas 2008 Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 2610 1635 1641